Found 31 matching trials
Indication of HSCT in Patients With Refractory/Relapse AA After First-line Standard Immunosuppressive Therapy Aged More Than 40 Years
PHASE2Outcomes for adult patients with Severe Aplastic Anemia (SAA) aged more tha...
Location
Saint Louis hospital
Immunological Tolerance in Patients With Mismatched Kidney Transplants
PHASE1This study seeks to determine if administration of the drug belumosudil (KD...
Status
Active Not Recruiting
Location
University of California, Los Angeles
A Safety and Efficacy Study of FCR001 Cell Therapy in Previously Transplanted Living Donor Kidney Recipients
PHASE2An open-label study to assess the safety, tolerability, and efficacy of FCR...
Location
Georgetown University Hospital
US Study of UM171-Expanded CB in Patients With High Risk Leukemia/Myelodysplasia
PHASE2Cord blood (CB) transplants are an option for patients lacking an HLA ident...
Location
University of Colorado School of Medicine. Anschutz Medical Campus
Islet Transplantation With Recipient T-Reg Cells or Deceased Donor Vertebral Bone Marrow Therapy
PHASE1The goal of this clinical trial is to learn if patients who have brittle ty...
Status
Enrolling By Invitation
Location
Stanford University
Reduced-Intensity Hematopoietic Stem Cell Transplant for High Risk Lysosomal and Peroxisomal Disorders
NAThis study is designed to test the ability to achieve donor hematopoietic e...
Location
Masonic Cancer Center, University of Minnesota
Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies
PHASE2Background:
Allogeneic blood or marrow transplant is when stem cells are t...
Location
National Institutes of Health Clinical Center
Renal Allograft Tolerance Through Mixed Chimerism - SMC/MGH
PHASE1The goal is to investigate the safety of the conditioning regimen, and its ...
Status
Active Not Recruiting
Location
Massachusetts General Hospital
Allogeneic Stem Cell Transplantation Followed By Targeted Immune Therapy In Average Risk Leukemia
PHASE1Allogeneic stem cell transplantation (AlloSCT) followed by targeted immune ...
Location
Columbia University Medical Center
US Study of ECT-001-CB in Pediatric and Young Adult Patients With High-Risk Myeloid Malignancies
PHASE1Cord blood (CB) transplants are an option for patients lacking an HLA ident...
Location
Memorial Sloan Kettering Cancer Center